Low Dose Naltrexone (LDN): Frequently Asked Questions (FAQs)
![Potential Benefits of Low Dose Naltrexone (LDN) and Frequently Asked Questions (FAQs)](https://scriptworksrx.com/wp-content/uploads/2024/07/SWR-July-2024-Blog1-potential-benefits-of-low-dose-naltrexone-faqs-california-1024x536.jpg)
At ScriptWorks Pharmacy, we get tons of questions about Low Dose Naltrexone (LDN) every day.
Topical Pain Medication: Compounding Personalized Pain Management Options
![Topical Pain Medication: Compounding Personalized Pain Management Options](https://scriptworksrx.com/wp-content/uploads/2024/06/topical-pain-medication-acute-chronic-ca-1024x536.jpg)
Topical pain medications are applied externally and are absorbed through the skin. Optimal viscosity, compatibility with the active ingredient, and skin compatibility should be considered.
Why California Practitioners Write Prescriptions for Compounded Ketamine
![](https://scriptworksrx.com/wp-content/uploads/2023/09/compounded-ketamine-prescription-compounding-pharmacy-featured-image.jpg)
Ketamine is a medication that was initially developed as an anesthetic and is commonly used in both medical and recreational contexts. It belongs to a class of drugs known as dissociative anesthetics, which can produce feelings of detachment from one’s surroundings and a sense of dissociation from reality.
A Deeper Look into Low Dose Naltrexone (LDN): Research & Insights
![](https://scriptworksrx.com/wp-content/uploads/2023/09/ldn-low-dose-naltrexone-research-compounding-1024x536.jpg)
Naltrexone is an opiate receptor antagonist. The 50-mg dose of Naltrexone was approved by the FDA for opioid and alcohol addiction in 1984. At much lower doses (0.5–9 mg per day), it may provide relief to patients suffering from autoimmune diseases, chronic pain, mental health diseases, and inflammation.
Low Dose Naltrexone: A Medical Game Changer
![](https://scriptworksrx.com/wp-content/uploads/2023/09/Low-Dose-Naltrexone-A-Medical-Game-Changer-Pain-Management-1024x536.jpg)
ScriptWorks has spent hours and hours researching and collaborating with healthcare professionals on Low Dose Naltrexone since 2014. Doctors and pharmacists around the world continue to study this fascinating therapy.